Invite a friend!

Targacept Inc

Address
200 E 1st St Ste 300 Winston Salem NC 27101
Phone
(336) 480-2100
Is this your business?
Claim it now!
Something wrong?
Submit a correction
Average Rating
0
Total Reviews
(0)
Leave a review with:
  1. 1 Star
  2. 2 Stars
  3. 3 Stars
  4. 4 Stars
  5. 5 Stars
Is this your business? Claim it now!
Share on
Share

Contact Us

Business Hours

Status: Closed

Sunday
Closed
Monday
9:00am-5:00pm
Tuesday
9:00am-5:00pm
Wednesday
9:00am-5:00pm
Thursday
9:00am-5:00pm
Friday
9:00am-5:00pm
Saturday
Closed

YellowBot Recommends

Signature Resource Group

  • 939 Burke St Winston Salem, NC 27101
  • (336) 723-7902

View Profile

Aaron-Elliott Locksmiths Inc

  • 301 W 8th St Winston Salem, NC 27101
  • (336) 722-2174

View Profile

Submit a correction

Know more about this business than we do? Cool! Please submit any corrections or missing details you may have.

Help us make it right

What the community has to say about Targacept Inc

Reviews of this business

Share a review

Business description (4)

Targacept can be found at E 1st St 200. The following is offered: Chemicals & Allied Products. The entry is present with us since Sep 9, 2010 and was last updated on Nov 14, 2013. In Winston Salem there are 12 other Chemicals & Allied Products. An overview can be found here.

Targacept is a biopharmaceutical company engaged in the design, discovery and development of a new class of drugs to treat diseases and disorders of the central nervous system. It is a leader in the field of neuronal nicotinic acetylcholine receptor chemistry and biology. NNRs are found on nerve cells throughout the nervous system and serve as key regulators of nervous system activity....

Targacept, Inc. is a biopharmaceutical company developing a diverse pipeline of NNR TherapeuticsTM. NNR Therapeutics selectively target neuronal nicotinic receptors, or NNRs. NNRs are found on nerve cells throughout the nervous system and serve as key regulators of nervous system activity.

Targacept's pharmaceutical research programs put a bull's-eye on the body's nicotine receptors. Targacept's drug candidates are being developed to address conditions related to cognitive impairment, depression, and pain by targeting neuronal nicotinic receptors (NNRs) in the nervous system using non-nicotine compounds. The firm hopes its drug candidates in clinical and pre-clinical development...

© 2007-2024 Solfo, Inc. – All rights reserved